HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric Lippert Selected Research

Hydroxyurea (Hydrea)

10/2023Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
10/2022Hemorrhages in Polycythemia Vera and Essential Thrombocythemia: Epidemiology, Description, and Risk Factors-Learnings from a Large Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric Lippert Research Topics

Disease

18Neoplasms (Cancer)
06/2023 - 01/2012
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2015 - 09/2008
8Polycythemia Vera
10/2023 - 11/2002
5Hemorrhage
10/2022 - 08/2019
4Thrombosis (Thrombus)
01/2022 - 03/2011
4Essential Thrombocythemia
01/2018 - 10/2004
4Polycythemia (Erythrocytosis)
05/2011 - 11/2002
3Thrombocytosis (Thrombocythemia)
01/2020 - 10/2004
3Primary Myelofibrosis (Myelosclerosis)
01/2018 - 03/2011
2Atrial Fibrillation
10/2022 - 01/2022
2Hematologic Neoplasms (Hematological Malignancy)
11/2020 - 11/2015
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2020 - 11/2017
2Inflammation (Inflammations)
08/2020 - 08/2003
2Myeloproliferative Disorders (Myeloproliferative Disorder)
12/2011 - 12/2007
1Pulmonary Embolism
01/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2018
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2017
1Venous Thromboembolism
03/2017
1Residual Neoplasm
01/2016
1Genetic Translocation (Chromosomal Translocation)
05/2013
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2013
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2012
1Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
07/2012
1Hemolytic Anemia
07/2012
1Refractory Anemia
07/2012
1Leukemia
03/2011
1Chromosome Aberrations (Chromosome Abnormalities)
09/2010
1Hypoxia (Hypoxemia)
01/2006
1Pneumonia (Pneumonitis)
08/2003

Drug/Important Bio-Agent (IBA)

7Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2022 - 06/2016
7Imatinib Mesylate (Gleevec)FDA Link
11/2015 - 09/2008
3ruxolitinibIBA
10/2023 - 01/2016
3AnticoagulantsIBA
01/2022 - 10/2017
2Hydroxyurea (Hydrea)FDA LinkGeneric
10/2023 - 10/2022
2RNA Precursors (Precursor, mRNA)IBA
11/2020 - 01/2020
2AntigensIBA
08/2020 - 01/2006
2CytokinesIBA
08/2020 - 11/2002
2InterferonsIBA
07/2020 - 01/2018
2Messenger RNA (mRNA)IBA
01/2020 - 09/2006
2CalreticulinIBA
12/2019 - 03/2017
2Proteins (Proteins, Gene)FDA Link
11/2017 - 12/2007
2Tyrosine Kinase InhibitorsIBA
10/2013 - 01/2013
2Janus Kinase 2IBA
07/2012 - 12/2011
2nilotinibFDA Link
01/2012 - 08/2011
2ErythropoietinFDA Link
05/2011 - 06/2005
1Syntex adjuvant formulationIBA
06/2023
1Fibrinogen (Factor I)FDA Link
01/2023
1fibrin fragment D (D-dimer)IBA
01/2023
1apixabanIBA
01/2022
1RivaroxabanIBA
01/2022
1anagrelide (Agrylin)FDA LinkGeneric
05/2021
1RNA (Ribonucleic Acid)IBA
11/2020
1RNA Splicing FactorsIBA
11/2020
1sphingosyl beta-glucosideIBA
08/2020
1Interleukin-33IBA
08/2020
1LeptinIBA
08/2020
14,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA
01/2020
1Thrombopoietin (c-mpl Ligand)IBA
01/2020
1KaolinIBA
01/2020
1Janus KinasesIBA
12/2019
1MicroRNAs (MicroRNA)IBA
11/2018
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018
1Vitamin KFDA Link
01/2018
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2015
1Genetic Markers (Genetic Marker)IBA
01/2014
1MethyltransferasesIBA
01/2014
1ponatinibIBA
10/2013
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2013
1PorphyrinsIBA
07/2012
1Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
07/2012
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2012
1Indicators and Reagents (Reagents)IBA
12/2011
1Hemoglobins (Hemoglobin)IBA
03/2011
1Biomarkers (Surrogate Marker)IBA
12/2007
1Apolipoprotein A-I (Apolipoprotein A1)IBA
12/2007
1DNA (Deoxyribonucleic Acid)IBA
09/2006
1CD34 Antigens (CD34 Antigen)IBA
01/2006
1CollagenIBA
10/2004
1GTP-Binding Proteins (G-Protein)IBA
08/2003
1AllergensIBA
08/2003
1ChemokinesIBA
08/2003
1Interleukin-8 (Interleukin 8)IBA
11/2002
1InterleukinsIBA
11/2002
1Interleukin-11 (Interleukin 11)IBA
11/2002

Therapy/Procedure

9Therapeutics
01/2018 - 09/2010
1Secondary Prevention
01/2022
1Plasma Exchange
08/2019
1Electrodes (Electrode)
06/2016
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2016
1Homologous Transplantation
10/2013